Copyright Reports & Markets. All rights reserved.

Global Solid Preparation Drug Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Solid Preparation Drug by Type
    • 1.3.1 Overview: Global Solid Preparation Drug Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Solid Preparation Drug Consumption Value Market Share by Type in 2025
    • 1.3.3 Tablet
    • 1.3.4 Capsules
    • 1.3.5 Other
  • 1.4 Global Solid Preparation Drug Market by Application
    • 1.4.1 Overview: Global Solid Preparation Drug Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Retail Pharmacy
    • 1.4.4 Other
  • 1.5 Global Solid Preparation Drug Market Size & Forecast
  • 1.6 Global Solid Preparation Drug Market Size and Forecast by Region
    • 1.6.1 Global Solid Preparation Drug Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Solid Preparation Drug Market Size by Region, (2021-2032)
    • 1.6.3 North America Solid Preparation Drug Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Solid Preparation Drug Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Solid Preparation Drug Market Size and Prospect (2021-2032)
    • 1.6.6 South America Solid Preparation Drug Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Solid Preparation Drug Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Johnson & Johnson
    • 2.1.1 Johnson & Johnson Details
    • 2.1.2 Johnson & Johnson Major Business
    • 2.1.3 Johnson & Johnson Solid Preparation Drug Product and Solutions
    • 2.1.4 Johnson & Johnson Solid Preparation Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Johnson & Johnson Recent Developments and Future Plans
  • 2.2 Novartis
    • 2.2.1 Novartis Details
    • 2.2.2 Novartis Major Business
    • 2.2.3 Novartis Solid Preparation Drug Product and Solutions
    • 2.2.4 Novartis Solid Preparation Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Novartis Recent Developments and Future Plans
  • 2.3 Roche
    • 2.3.1 Roche Details
    • 2.3.2 Roche Major Business
    • 2.3.3 Roche Solid Preparation Drug Product and Solutions
    • 2.3.4 Roche Solid Preparation Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Roche Recent Developments and Future Plans
  • 2.4 AbbVie
    • 2.4.1 AbbVie Details
    • 2.4.2 AbbVie Major Business
    • 2.4.3 AbbVie Solid Preparation Drug Product and Solutions
    • 2.4.4 AbbVie Solid Preparation Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 AbbVie Recent Developments and Future Plans
  • 2.5 Merck & Co.
    • 2.5.1 Merck & Co. Details
    • 2.5.2 Merck & Co. Major Business
    • 2.5.3 Merck & Co. Solid Preparation Drug Product and Solutions
    • 2.5.4 Merck & Co. Solid Preparation Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Merck & Co. Recent Developments and Future Plans
  • 2.6 Bristol Myers Squibb
    • 2.6.1 Bristol Myers Squibb Details
    • 2.6.2 Bristol Myers Squibb Major Business
    • 2.6.3 Bristol Myers Squibb Solid Preparation Drug Product and Solutions
    • 2.6.4 Bristol Myers Squibb Solid Preparation Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Bristol Myers Squibb Recent Developments and Future Plans
  • 2.7 GlaxoSmithKline
    • 2.7.1 GlaxoSmithKline Details
    • 2.7.2 GlaxoSmithKline Major Business
    • 2.7.3 GlaxoSmithKline Solid Preparation Drug Product and Solutions
    • 2.7.4 GlaxoSmithKline Solid Preparation Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 GlaxoSmithKline Recent Developments and Future Plans
  • 2.8 Pfizer
    • 2.8.1 Pfizer Details
    • 2.8.2 Pfizer Major Business
    • 2.8.3 Pfizer Solid Preparation Drug Product and Solutions
    • 2.8.4 Pfizer Solid Preparation Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Pfizer Recent Developments and Future Plans
  • 2.9 Sanofi
    • 2.9.1 Sanofi Details
    • 2.9.2 Sanofi Major Business
    • 2.9.3 Sanofi Solid Preparation Drug Product and Solutions
    • 2.9.4 Sanofi Solid Preparation Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Sanofi Recent Developments and Future Plans
  • 2.10 Takeda
    • 2.10.1 Takeda Details
    • 2.10.2 Takeda Major Business
    • 2.10.3 Takeda Solid Preparation Drug Product and Solutions
    • 2.10.4 Takeda Solid Preparation Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Takeda Recent Developments and Future Plans
  • 2.11 AstraZeneca
    • 2.11.1 AstraZeneca Details
    • 2.11.2 AstraZeneca Major Business
    • 2.11.3 AstraZeneca Solid Preparation Drug Product and Solutions
    • 2.11.4 AstraZeneca Solid Preparation Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 AstraZeneca Recent Developments and Future Plans
  • 2.12 Bayer
    • 2.12.1 Bayer Details
    • 2.12.2 Bayer Major Business
    • 2.12.3 Bayer Solid Preparation Drug Product and Solutions
    • 2.12.4 Bayer Solid Preparation Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Bayer Recent Developments and Future Plans
  • 2.13 Eli Lilly & Co.
    • 2.13.1 Eli Lilly & Co. Details
    • 2.13.2 Eli Lilly & Co. Major Business
    • 2.13.3 Eli Lilly & Co. Solid Preparation Drug Product and Solutions
    • 2.13.4 Eli Lilly & Co. Solid Preparation Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Eli Lilly & Co. Recent Developments and Future Plans
  • 2.14 Gilead Sciences
    • 2.14.1 Gilead Sciences Details
    • 2.14.2 Gilead Sciences Major Business
    • 2.14.3 Gilead Sciences Solid Preparation Drug Product and Solutions
    • 2.14.4 Gilead Sciences Solid Preparation Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Gilead Sciences Recent Developments and Future Plans
  • 2.15 Amgen
    • 2.15.1 Amgen Details
    • 2.15.2 Amgen Major Business
    • 2.15.3 Amgen Solid Preparation Drug Product and Solutions
    • 2.15.4 Amgen Solid Preparation Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Amgen Recent Developments and Future Plans
  • 2.16 Teva
    • 2.16.1 Teva Details
    • 2.16.2 Teva Major Business
    • 2.16.3 Teva Solid Preparation Drug Product and Solutions
    • 2.16.4 Teva Solid Preparation Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Teva Recent Developments and Future Plans
  • 2.17 Boehringer Ingelheim
    • 2.17.1 Boehringer Ingelheim Details
    • 2.17.2 Boehringer Ingelheim Major Business
    • 2.17.3 Boehringer Ingelheim Solid Preparation Drug Product and Solutions
    • 2.17.4 Boehringer Ingelheim Solid Preparation Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Boehringer Ingelheim Recent Developments and Future Plans
  • 2.18 Biogen
    • 2.18.1 Biogen Details
    • 2.18.2 Biogen Major Business
    • 2.18.3 Biogen Solid Preparation Drug Product and Solutions
    • 2.18.4 Biogen Solid Preparation Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 Biogen Recent Developments and Future Plans
  • 2.19 Astellas
    • 2.19.1 Astellas Details
    • 2.19.2 Astellas Major Business
    • 2.19.3 Astellas Solid Preparation Drug Product and Solutions
    • 2.19.4 Astellas Solid Preparation Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.19.5 Astellas Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Solid Preparation Drug Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Solid Preparation Drug by Company Revenue
    • 3.2.2 Top 3 Solid Preparation Drug Players Market Share in 2025
    • 3.2.3 Top 6 Solid Preparation Drug Players Market Share in 2025
  • 3.3 Solid Preparation Drug Market: Overall Company Footprint Analysis
    • 3.3.1 Solid Preparation Drug Market: Region Footprint
    • 3.3.2 Solid Preparation Drug Market: Company Product Type Footprint
    • 3.3.3 Solid Preparation Drug Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Solid Preparation Drug Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Solid Preparation Drug Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Solid Preparation Drug Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Solid Preparation Drug Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Solid Preparation Drug Consumption Value by Type (2021-2032)
  • 6.2 North America Solid Preparation Drug Market Size by Application (2021-2032)
  • 6.3 North America Solid Preparation Drug Market Size by Country
    • 6.3.1 North America Solid Preparation Drug Consumption Value by Country (2021-2032)
    • 6.3.2 United States Solid Preparation Drug Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Solid Preparation Drug Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Solid Preparation Drug Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Solid Preparation Drug Consumption Value by Type (2021-2032)
  • 7.2 Europe Solid Preparation Drug Consumption Value by Application (2021-2032)
  • 7.3 Europe Solid Preparation Drug Market Size by Country
    • 7.3.1 Europe Solid Preparation Drug Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Solid Preparation Drug Market Size and Forecast (2021-2032)
    • 7.3.3 France Solid Preparation Drug Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Solid Preparation Drug Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Solid Preparation Drug Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Solid Preparation Drug Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Solid Preparation Drug Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Solid Preparation Drug Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Solid Preparation Drug Market Size by Region
    • 8.3.1 Asia-Pacific Solid Preparation Drug Consumption Value by Region (2021-2032)
    • 8.3.2 China Solid Preparation Drug Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Solid Preparation Drug Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Solid Preparation Drug Market Size and Forecast (2021-2032)
    • 8.3.5 India Solid Preparation Drug Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Solid Preparation Drug Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Solid Preparation Drug Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Solid Preparation Drug Consumption Value by Type (2021-2032)
  • 9.2 South America Solid Preparation Drug Consumption Value by Application (2021-2032)
  • 9.3 South America Solid Preparation Drug Market Size by Country
    • 9.3.1 South America Solid Preparation Drug Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Solid Preparation Drug Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Solid Preparation Drug Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Solid Preparation Drug Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Solid Preparation Drug Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Solid Preparation Drug Market Size by Country
    • 10.3.1 Middle East & Africa Solid Preparation Drug Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Solid Preparation Drug Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Solid Preparation Drug Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Solid Preparation Drug Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Solid Preparation Drug Market Drivers
  • 11.2 Solid Preparation Drug Market Restraints
  • 11.3 Solid Preparation Drug Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Solid Preparation Drug Industry Chain
  • 12.2 Solid Preparation Drug Upstream Analysis
  • 12.3 Solid Preparation Drug Midstream Analysis
  • 12.4 Solid Preparation Drug Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Solid Preparation Drug market size was valued at US$ 672490 million in 2025 and is forecast to a readjusted size of US$ 1023230 million by 2032 with a CAGR of 6.2% during review period.
    Solid dosage form means any of the many pharmacy dosage forms like tablets, capsules, caplets, pills, powders, troches, lozenges, cachets, pellets or confections which are solid and which are not in liquid or gaseous form.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global Solid Preparation Drug market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Solid Preparation Drug market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Solid Preparation Drug market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Solid Preparation Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Solid Preparation Drug market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Solid Preparation Drug
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Solid Preparation Drug market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson & Johnson, Novartis, Roche, AbbVie, Merck & Co., Bristol Myers Squibb, GlaxoSmithKline, Pfizer, Sanofi, Takeda, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Solid Preparation Drug market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Tablet
    Capsules
    Other
    Market segment by Application
    Hospital
    Retail Pharmacy
    Other
    Market segment by players, this report covers
    Johnson & Johnson
    Novartis
    Roche
    AbbVie
    Merck & Co.
    Bristol Myers Squibb
    GlaxoSmithKline
    Pfizer
    Sanofi
    Takeda
    AstraZeneca
    Bayer
    Eli Lilly & Co.
    Gilead Sciences
    Amgen
    Teva
    Boehringer Ingelheim
    Biogen
    Astellas
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Solid Preparation Drug product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Solid Preparation Drug, with revenue, gross margin, and global market share of Solid Preparation Drug from 2021 to 2026.
    Chapter 3, the Solid Preparation Drug competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Solid Preparation Drug market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Solid Preparation Drug.
    Chapter 13, to describe Solid Preparation Drug research findings and conclusion.

    Buy now